PD1 Resistance with a Multi-Omic Approach
PharmaTalkRadio10 Maalis 2020

PD1 Resistance with a Multi-Omic Approach

Anti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Danny Wells, Parker Institute for Cancer Immunotherapy will address: Orthogonality and correlation of response biomarkers across histologiesIntegration of multi-omic data sets for mechanistic insights into tumor immunobiologyThe translational approaches to PD1 resistance program at the Parker Institute To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
utelias-mieli
rss-mita-tulisi-tietaa
docemilia
rss-hereilla
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-astetta-parempi-elama-podcast
rss-tiedetta-vai-tarinaa
rss-ylistys-elaimille
mielipaivakirja
sotataidon-ytimessa
rss-sotepodi-ratkaisuja-hyvinvointiin
rss-kasvikutsut
rss-ammamafia
rss-bios-podcast
rss-tervetta-skeptisyytta
ihanat-ipanat